Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Mol Pharm ; 17(7): 2648-2659, 2020 07 06.
Artigo em Inglês | MEDLINE | ID: mdl-32412765

RESUMO

Photodynamic therapy (PDT) is a noninvasive therapy based on the photodynamic effect. In this study, we sought to determine intracellular uptake and in vivo photodynamic therapy potential of Zn phthalocyanine-loaded mesoporous silica nanoparticles (MSNP5) against pancreatic cancer cells. MSNP5 were labeled with 131I; the radiolabeling efficiency was found to 95.5 ± 1.2% in pH 9 and 60 min reaction time. Besides, the highest intracellular uptake yields of 131I-MSNP5 nanoparticles in MIA PaCa-2, AsPC-1, and PANC-1 cells were determined as 43.9 ± 3.8%, 41.8 ± 0.2%, and 37.9 ± 1.3%, respectively, at 24 h incubation time. In vivo PDT studies were performed with subcutaneous xenograft cancer model nude mice with AsPC-1 pancreatic cancer cells. For photodynamic therapy, 685 nm red laser light 100 J/cm2 light dose using and 5-20 µM ZnPc containing MSNP5 concentrations were applied. Histopathological studies revealed that the ratio of necrosis in tumor tissue was higher in the treatment group than the control groups.


Assuntos
Antineoplásicos Imunológicos/administração & dosagem , Cetuximab/administração & dosagem , Indóis/administração & dosagem , Nanopartículas Metálicas/química , Compostos Organometálicos/administração & dosagem , Neoplasias Pancreáticas/tratamento farmacológico , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/administração & dosagem , Animais , Linhagem Celular Tumoral , Terapia Combinada/métodos , Humanos , Concentração de Íons de Hidrogênio , Indóis/química , Radioisótopos do Iodo/química , Isoindóis , Lasers , Luz , Masculino , Camundongos , Camundongos Nus , Nanopartículas , Necrose , Compostos Organometálicos/química , Neoplasias Pancreáticas/imunologia , Neoplasias Pancreáticas/patologia , Neoplasias Pancreáticas/radioterapia , Dióxido de Silício/química , Ensaios Antitumorais Modelo de Xenoenxerto , Compostos de Zinco
2.
Int Urol Nephrol ; 46(2): 389-93, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-24014133

RESUMO

PURPOSE: Warm-ischemia-induced injuries might be encountered during renal transplants from cadavers and healthy donors. Toll-like receptors (TLR) in ischemia-reperfusion (I/R) injury are one of the indicators of intracellular injury pathways. The intensity of ischemic injury is directly proportionate to high TLR levels. To minimize the I/R injury, we investigated TLR2 and TLR4 levels on rats, which were pretreated with tacrolimus (FK506) before I/R. METHODS: Eight Wistar albino rats in the study group were administered .01 mg/kg intramuscular tacrolimus. Administration to the study group was performed 24 and 1 h before warm ischemia. Eight rats in the control group were injected with 0.1 c.c. of distilled water. Blood samples were collected from the tail veins of all the rats on the first, second and third days. Expression levels of TLR2 and TLR4 genes were analyzed using the polymerase chain reaction method, to determine any significant difference between the control and study groups on the days when blood was taken. RESULTS: TLR2 (p = 0.045) and TLR4 (p = 0.022) levels in the study group were found to be statistically, and significantly, lower than those in the control group, on the second day following warm-ischemia- and reperfusion-induced injury. CONCLUSIONS: Administration of immunosuppressive drugs to healthy donor rats led to a statistically significant reduction in the expression levels of TLR2 and TLR4 in the early period. In light of the data obtained by this study, we hypothesize that a preoperative therapy on donors might have a role in preventing I/R injury.


Assuntos
Imunossupressores/farmacologia , Traumatismo por Reperfusão/sangue , Tacrolimo/farmacologia , Receptor 2 Toll-Like/genética , Receptor 4 Toll-Like/genética , Animais , Expressão Gênica/efeitos dos fármacos , Imunossupressores/uso terapêutico , Transplante de Rim , Cuidados Pré-Operatórios , RNA/sangue , Ratos , Ratos Wistar , Traumatismo por Reperfusão/prevenção & controle , Tacrolimo/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa